Customized research for ATHX vs. ARDS!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ATHX vs. ARDS.


↗ Join Our Free Email Newsletter.




Athersys, Inc. vs. Aridis Pharmaceuticals Inc.

Industry Match! Industry of Both ATHX and ARDS:

Health Care/Life Sciences

ATHX
Data Last Updated: More than a wk ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 201.535M


P/E: N/A

P/S: 8.3

Q P/B: 6.06

Y Rev: 24.29M

Q Rev: 4.26M

Beta: 0.74

ATHX Share Stats

Outstanding Shares

149.78M

Float Shares

136.86M

Percent of Float Short

9.72%

ATHX Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

ATHX Social Stats

Followers

3

B/S Rating Today

0

B/S Rating All-Time

+1

More Social Data

ATHX in Pulse Portal

Stream of Posts

ATHX Symbol Page

Share ATHX Insights

Express Sentiment

'Buy' or 'Sell' ATHX

ATHX Profile

CEO

Dr. Gil van Bokkelen

Exchange

Nasdaq

Employees

75.00

About

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions...

ATHX Financials

Annual Financials

Income Statement

Revenue

24.29M

Net Income

(24.28M)

Cash Flow Statement

Change in Cash / Investments

21.74M

Balance Sheet

Cash / Investments

51.06M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

57.84M

Total Current Liabilities

15.48M

Total Assets

61.73M

Total Liabilities

18.61M

Stockholder Equity

43.12M

Quarterly Financials

Income Statement

Q Revenue

4.26M

Q Net Income

(9.69M)

Cash Flow Statement

Q Change in Cash / Investments

(6.78M)

Balance Sheet

Q Cash / Investments

44.24M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

48.07M

Q Total Current Liabilities

14.68M

Q Total Assets

53.25M

Q Total Liabilities

20M

Q Stockholder Equity

33.25M

ATHX Charts

10-Year Chart

ATHX 10-Year Chart

5-Year Chart

ATHX 5-Year Chart

1-Year Chart

ATHX 1-Year Chart

6-Month Chart

ATHX 6-Month Chart

3-Month Chart

ATHX 3-Month Chart

1-Month Chart

ATHX 1-Month Chart

1-Day Chart

ATHX 1-Day Chart

ARDS
Data Last Updated: 4 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 72.1M


P/E: N/A

P/S: 26.12

Q P/B: 6.64

Y Rev: 2.76M

Q Rev: -

Beta: N/A

ARDS Share Stats

Outstanding Shares

8.11M

Float Shares

4.80M

Percent of Float Short

0.22%

ARDS Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

ARDS Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ARDS in Pulse Portal

Stream of Posts

ARDS Symbol Page

Share ARDS Insights

Express Sentiment

'Buy' or 'Sell' ARDS

ARDS Profile

CEO

Dr. Eric J. Patzer

Exchange

Nasdaq

Employees

28.00

About

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-105, AR-101, AR-401, AR-201, and AR-501. The company...

ARDS Financials

Annual Financials

Income Statement

Revenue

2.76M

Net Income

(22.11M)

Cash Flow Statement

Change in Cash / Investments

(859,000)

Balance Sheet

Cash / Investments

24.24M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

28.35M

Total Current Liabilities

5.3M

Total Assets

31.61M

Total Liabilities

5.3M

Stockholder Equity

26.31M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(8.38M)

Cash Flow Statement

Q Change in Cash / Investments

(7.79M)

Balance Sheet

Q Cash / Investments

8.52M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

13.36M

Q Total Current Liabilities

5.01M

Q Total Assets

15.87M

Q Total Liabilities

5.01M

Q Stockholder Equity

10.86M

ARDS Charts

10-Year Chart

ARDS 10-Year Chart

5-Year Chart

ARDS 5-Year Chart

1-Year Chart

ARDS 1-Year Chart

6-Month Chart

ARDS 6-Month Chart

3-Month Chart

ARDS 3-Month Chart

1-Month Chart

ARDS 1-Month Chart

1-Day Chart

ARDS 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon